Meeting
2023 ASCO Quality Care Symposium
Risk factors predicting clinical oncology pharmacists’ medication modifications.
Authors
Emily R. Mackler
Michigan Oncology Quality Consortium and Michigan Institute for Care Management and Transformation, Ann Arbor, MI
Emily R. Mackler, David Reyes-Gastelum, Katie Young, Julie Wietzke, Ashley Schwartz, Karen B. Farris
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Team-Based Approaches to Care Delivery
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 54)
DOI
10.1200/OP.2023.19.11_suppl.54
Abstract #
54
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Next-generation sequencing (NGS) for identifying actionable molecular alterations in patients with newly diagnosed and recurrent IDHwt-glioblastoma (GBM): A large mono-institutional experience.
First Author: Marta Padovan
Poster
2020 ASCO Virtual Scientific Program
Prevalence and predictors of high-intensity end-of-life care among adolescents and young adults with cancer in Ontario: a population-based study using the IMPACT cohort.
First Author: Hallie Coltin
Poster
2018 ASCO Annual Meeting
Treatment of metastatic uveal melanoma (mUM) directed by a comprehensive molecular tumour analysis program (CMTA).
First Author: Serge Leyvraz
Poster
2024 ASCO Breakthrough
Research and analysis on the situation of diagnosis and treatment capabilities of breast cancer in China county.
First Author: Xiang Tan